ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO797

Renal Transplant Outcomes Among Pediatric Non-English Language Preference Patients

Session Information

Category: Diversity and Equity in Kidney Health

  • 900 Diversity and Equity in Kidney Health


  • Astudillo, Yaritzy Michelle, Westchester Medical Center, Valhalla, New York, United States
  • Le, Ponmali, Westchester Medical Center, Valhalla, New York, United States
  • Solomon, Sonia, Westchester Medical Center, Valhalla, New York, United States

Non-English language preference (NELP) is associated with disparities in health care access and quality and worse clinical outcomes in children. To our knowledge, no studies characterize the role of NELP in the renal transplant process. The primary aim of this study is to compare pediatric renal transplant outcomes among NELP and English Language Preference (ELP) populations.


This retrospective single-center study included pediatric patients between the ages of 0 to 21 who received renal transplants between January 2014 and September 2022. The determination of NELP was made based on interpreter use, language spoken at home, or explicit documentation of NELP in the electronic medical record. Proportions were compared using Mann-Whitney, Chi-squared tests, and unpaired t-test. Two-tailed p values of <0.05 were considered significant.


45 renal transplant recipients were included. 26% (12) of these patients were identified as NELP. The average age at transplant for NELP patients was 12.3 (± 5.3) and ELP was 10.7 (± 5.4). Those identified as NELP were significantly less likely to have a living donor transplant (p<0.01). Worsened eGFR was seen in the NELP cohort at 7.43 compared to ELP at 5.91 (p=0.12). Rejection and graft failure were more likely in the NELP cohort (50% vs 33%, p=0.30 and 17% vs 3%, p=0.10, respectively). There was no statistical difference in viral activity.


NELP patients were less likely to receive living donor grafts, demonstrating an ongoing disparity. Although not statistically significant, NELP rejection and graft failures appear to be clinically significant for long-term outcomes. Our results suggest NELP is a risk factor for poor transplant outcomes in children. Our single-center study is limited given small sample size. Larger multi-centered studies are needed to identify interventions for bridging the gap among NELP patients.